|
PRPSAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.055700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.905800E-02 |
| Normal-vs-Stage2 |
2.318000E-02 |
| Normal-vs-Stage3 |
4.319400E-03 |
| Normal-vs-Stage4 |
2.253400E-01 |
| Stage1-vs-Stage2 |
4.362200E-01 |
| Stage1-vs-Stage3 |
1.361980E-01 |
| Stage1-vs-Stage4 |
9.279400E-01 |
| Stage2-vs-Stage3 |
5.948800E-01 |
| Stage2-vs-Stage4 |
6.226800E-01 |
| Stage3-vs-Stage4 |
3.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.698300E-02 |
| Normal-vs-AfricanAmerican |
1.699730E-02 |
| Normal-vs-Asian |
2.064800E-01 |
| Caucasian-vs-AfricanAmerican |
5.134600E-01 |
| Caucasian-vs-Asian |
7.634000E-01 |
| AfricanAmerican-vs-Asian |
8.923600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.224300E-03 |
| Normal-vs-Female |
6.623200E-01 |
| Male-vs-Female |
3.455900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.787500E-02 |
| Normal-vs-Extreme_Weight |
4.487500E-02 |
| Normal-vs-Obese |
2.431800E-02 |
| Normal-vs-Extreme_Obese |
2.571600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.952600E-01 |
| Normal_Weight-vs-Obese |
9.055400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.135400E-01 |
| Extreme_Weight-vs-Obese |
8.707400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.376200E-01 |
| Obese-vs-Extreme_Obese |
7.543600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.503800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.604950E-01 |
| Normal-vs-Age(61-80Yrs) |
1.545870E-02 |
| Normal-vs-Age(81-100Yrs) |
2.236000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.495600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.790810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.716020E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.454830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.843640E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.230200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.723430E-01 |
| Normal-VS-Type2 PRCC |
3.939400E-03 |
| Normal-VS-KIRP CIMP |
5.966100E-02 |
| Normal-VS-Unclassified PRCC |
1.410000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.999200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.577400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.242800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.172800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.334800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.799700E-04 |
| Normal-vs-N1 |
9.944800E-03 |
| Normal-vs-N2 |
1.233640E-01 |
| N0-vs-N1 |
8.342200E-01 |
| N0-vs-N2 |
7.738000E-01 |
| N1-vs-N2 |
7.523000E-01 |
|
|
